ResearcherCopenhagen University HospitalNo recent work listed

Liva K. Stuhr

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-7753-4716; OpenAlex author ID A5107568243. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15030897 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lars Henrik Jensen · 1 shared paper, 2023 · strength 0.18
- Paper Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15030897 ↗
Astrid Zedlitz Johansen · 1 shared paper, 2023 · strength 0.18
- Paper Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15030897 ↗
Julia Sidenius Johansen · 1 shared paper, 2023 · strength 0.18
- Paper Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15030897 ↗
Carsten Palnæs Hansen · 1 shared paper, 2023 · strength 0.18
- Paper Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15030897 ↗
Inna Markovna Chen · 1 shared paper, 2023 · strength 0.18
- Paper Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15030897 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.